The US Food and Drug Administration (FDA) has warned an active pharmaceutical ingredient (API) maker in India for falsifying manufacturing records and issued a warning letter to a contract testing lab ...
The FDA chastised a pair of India-based API manufacturers in separate warning letters outlining poor record-keeping and other problems. () The FDA has chastised a pair of India-based API manufacturers ...
A US manufacturer of active pharmaceutical ingredients (API) was lambasted in a recent warning letter by the US Food and Drug Administration (FDA) for multiple good manufacturing practice (GMP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results